Skip to Main Content

Author Details

Sudhakar Agnihothram
National Center for Toxicological Research
2005
36
25
PMIDPaper TitleJournal TitlePublished Year
34013261Common Mechanism of SARS-CoV and SARS-CoV-2 Pathogenesis across Species.bioRxiv2021
32661400Author Correction: A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence.Nat Med2020
31136294Reduced vancomycin susceptibility and increased macrophage survival in Staphylococcus aureus strains sequentially isolated from a bacteraemic patient during a short course of antibiotic therapy.J Med Microbiol2019
29540599Development of a Broadly Accessible Venezuelan Equine Encephalitis Virus Replicon Particle Vaccine Platform.J Virol2018
28596388Draft Genome Sequences of Two <i>Staphylococcus aureus</i> Strains Isolated in Succession from a Case of Bacteremia.Genome Announc2017
29974891Viral and Bacterial Co-Infection and Its Implications.SciFed Virol Res J2017
27050591Corrigendum: A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence.Nat Med2016
29930994Titanium Dioxide Nanoparticles Evoke Proinflammatory Response during Murine Norovirus Infection Despite Having Minimal Effects on Virus Replication.Int J Nanotechnol Eng Med2016
27287409Airway Memory CD4(+) T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses.Immunity2016
27547159Silicon Dioxide Impedes Antiviral Response and Causes Genotoxic Insult During Calicivirus Replication.J Nanosci Nanotechnol2016
26976607SARS-like WIV1-CoV poised for human emergence.Proc Natl Acad Sci U S A2016
26015500Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection.mBio2015
26658916Infection of Murine Macrophages by Salmonella enterica Serovar Heidelberg Blocks Murine Norovirus Infectivity and Virus-induced Apoptosis.PLoS One2015
26552008A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence.Nat Med2015
26216974Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus.Proc Natl Acad Sci U S A2015
24253287Evaluation of serologic and antigenic relationships between middle eastern respiratory syndrome coronavirus and other coronaviruses to develop vaccine platforms for the rapid response to emerging coronaviruses.J Infect Dis2014
25977790A comprehensive collection of systems biology data characterizing the host response to viral infection.Sci Data2014
25534508Cytokine systems approach demonstrates differences in innate and pro-inflammatory host responses between genetically distinct MERS-CoV isolates.BMC Genomics2014
25100850A chimeric virus-mouse model system for evaluating the function and inhibition of papain-like proteases of emerging coronaviruses.J Virol2014
24778221Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution.Proc Natl Acad Sci U S A2014
24574399Mouse dipeptidyl peptidase 4 is not a functional receptor for Middle East respiratory syndrome coronavirus infection.J Virol2014
24599590Rapid generation of a mouse model for Middle East respiratory syndrome.Proc Natl Acad Sci U S A2014
24667706A mouse model for Betacoronavirus subgroup 2c using a bat coronavirus strain HKU5 variant.mBio2014
24478444Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-o-methyltransferase activity.J Virol2014
23552422Tropism of and innate immune responses to the novel human betacoronavirus lineage C virus in human ex vivo respiratory organ cultures.J Virol2013
24510290Human norovirus detection and production, quantification, and storage of virus-like particles.Curr Protoc Microbiol2013
24043791Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus.Proc Natl Acad Sci U S A2013
23903833Crystal structure of the receptor-binding domain from newly emerged Middle East respiratory syndrome coronavirus.J Virol2013
23631916Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus.mBio2013
22072787Molecular determinants of severe acute respiratory syndrome coronavirus pathogenesis and virulence in young and aged mouse models of human disease.J Virol2012
22993147Evidence supporting a zoonotic origin of human coronavirus strain NL63.J Virol2012
21937658A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge.J Virol2011
19625404Assembly of arenavirus envelope glycoprotein GPC in detergent-soluble membrane microdomains.J Virol2009
17267481Bitopic membrane topology of the stable signal peptide in the tripartite Junín virus GP-C envelope glycoprotein complex.J Virol2007
16698999Role of the stable signal peptide and cytoplasmic domain of G2 in regulating intracellular transport of the Junín virus envelope glycoprotein complex.J Virol2006
16169032Genetic analysis of heptad-repeat regions in the G2 fusion subunit of the Junín arenavirus envelope glycoprotein.Virology2005
  • 1 - 36 of 36

Recommended Authors

Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year 2017
Number of shared co-authors 5
Gladstone Institutes
Career Start Year 2016
Number of shared co-authors 2
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Career Start Year 2015
Number of shared co-authors 1
University of Maryland School of Medicine
Career Start Year 2014
Number of shared co-authors 4
Texas Biomedical Research Institute
Career Start Year 2013
Number of shared co-authors 0
University of Texas Medical Branch
Career Start Year 2012
Number of shared co-authors 1
Indian Institute of Science
Career Start Year 2011
Number of shared co-authors 3
Stanford University School of Medicine
Career Start Year 2010
Number of shared co-authors 3
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2010
Number of shared co-authors 2
Yale School of Medicine
Career Start Year 2010
Number of shared co-authors 4
University of Texas Medical Branch
Career Start Year 2009
Number of shared co-authors 18
University of Texas Medical Branch
Career Start Year 2008
Number of shared co-authors 2
Icahn School of Medicine at Mount Sinai
Career Start Year 2008
Number of shared co-authors 1
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 3
Boston University Chobanian and Avedisian School of Medicine
Career Start Year 2007
Number of shared co-authors 0
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 2004
Number of shared co-authors 5
Centers for Disease Control and Prevention (CDC)
Career Start Year 2003
Number of shared co-authors 9
University of Iowa
Career Start Year 2002
Number of shared co-authors 5
Texas Biomedical Research Institute
Career Start Year 2001
Number of shared co-authors 8
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1998
Number of shared co-authors 11
University of Texas Medical Branch
Career Start Year 1997
Number of shared co-authors 4
Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 5
University of Cambridge
Career Start Year 1996
Number of shared co-authors 2
Icahn School of Medicine at Mount Sinai
Career Start Year 1995
Number of shared co-authors 5
Vanderbilt University Medical Center
Career Start Year 1995
Number of shared co-authors 9
Icahn School of Medicine at Mount Sinai
Career Start Year 1994
Number of shared co-authors 2
University College London
Career Start Year 1992
Number of shared co-authors 1
The University of Texas Medical Branch
Career Start Year 1991
Number of shared co-authors 23
Icahn School of Medicine at Mount Sinai
Career Start Year 1989
Number of shared co-authors 29
Erasmus Medical Center
Career Start Year 1986
Number of shared co-authors 13

Collaborators

University of North Carolina
Co-authored papers 26
University of North Carolina at Chapel Hill
Co-authored papers 14
University of Texas Medical Branch
Co-authored papers 13
University of North Carolina at Chapel Hill
Co-authored papers 11
University of North Carolina
Co-authored papers 10
Co-authored papers 8
University of North Carolina at Chapel Hill.
Co-authored papers 6
Co-authored papers 5
University of Washington
Co-authored papers 5
University of North Carolina at Chapel Hill
Co-authored papers 4
Co-authored papers 4
The University of North Carolina at Chapel Hill
Co-authored papers 3
Institut des Agents Infectieux, Infective Agents Institute, North Hospital Network
Co-authored papers 3
Altius Institute for Biomedical Sciences
Co-authored papers 3
University of North Carolina at Chapel Hill
Co-authored papers 3
University of North Carolina.
Co-authored papers 3
United States Army Medical Research Institute of Infectious Diseases
Co-authored papers 3
Center for Innate Immunity and Immune Disease, University of Washington
Co-authored papers 2
Center for Pathogen Research, University of Maryland School of Medicine
Co-authored papers 2
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
University of Maryland School of Medicine
Co-authored papers 2
University of Washington
Co-authored papers 2
Vanderbilt University Medical Center
Co-authored papers 2
Oregon Health & Science University, University of California Berkeley
Co-authored papers 2
University of Washington, USA Washington National Primate Research Center
Co-authored papers 2
University of Washington, USA Washington National Primate Research Center
Co-authored papers 2
J. Craig Venter Institute
Co-authored papers 1
Pacific Northwest National Laboratory
Co-authored papers 1
University of North Carolina
Co-authored papers 1
Marsico Lung Institute, University of North Carolina-Chapel Hill
Co-authored papers 1